Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1415)
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
312
Price
$54.34
Total Value
$16.96K
Shares Held After
134,903
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
6,417
Price
$56.12
Total Value
$360.13K
Shares Held After
452,466
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
9,137
Price
$55.27
Total Value
$504.96K
Shares Held After
458,883
% of Holdings
2.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
6,683
Price
$54.27
Total Value
$362.72K
Shares Held After
468,020
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
51,858
Price
$106.50
Total Value
$5.52M
Shares Held After
78,787
% of Holdings
39.7%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
113,289
Price
$106.50
Total Value
$12.07M
Shares Held After
240,123
% of Holdings
32.1%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
627,597
Price
$106.50
Total Value
$66.84M
Shares Held After
1,592,261
% of Holdings
28.3%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
837,914
Price
$106.50
Total Value
$89.24M
Shares Held After
1,960,881
% of Holdings
29.9%
Legend Biotech Corp (LEGN)
Huang Ying — Director
Shares
5,566
Price
$14.78
Total Value
$82.27K
Shares Held After
241,872
% of Holdings
2.2%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
24,100
Price
$30.38
Total Value
$732.16K
Shares Held After
30,547
% of Holdings
44.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
24,100
Price
$30.38
Total Value
$732.16K
Shares Held After
11,223
% of Holdings
68.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
510
Price
$2.56
Total Value
$1.31K
Shares Held After
2,393,902
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
145,880
Price
$2.48
Total Value
$361.78K
Shares Held After
2,393,392
% of Holdings
6.1%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
52,084
Price
$20.18
Total Value
$1.05M
Shares Held After
15,625
% of Holdings
76.9%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$20.50
Total Value
$102.50K
Shares Held After
406,775
% of Holdings
1.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.79K
Shares Held After
131,669
% of Holdings
1.7%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.77K
Shares Held After
56,450
% of Holdings
3.9%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
500,000
Price
$34.13
Total Value
$17.07M
Shares Held After
18,677,617
% of Holdings
2.6%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
3,400
Price
$35.09
Total Value
$119.31K
Shares Held After
65,631
% of Holdings
4.9%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
11,600
Price
$34.45
Total Value
$399.67K
Shares Held After
69,031
% of Holdings
14.4%
CG Oncology, Inc. (CGON)
Liu Brian Guan-Chyun — Director
Shares
371,085
Price
$66.87
Total Value
$24.81M
Shares Held After
1,886,236
% of Holdings
19.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
14,420
Price
$20.66
Total Value
$297.92K
Shares Held After
15,805
% of Holdings
47.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
40,580
Price
$19.56
Total Value
$793.74K
Shares Held After
30,225
% of Holdings
57.3%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
31,000
Price
$8.88
Total Value
$275.28K
Shares Held After
16,794,043
% of Holdings
0.2%
Passage BIO, Inc. (PASG)
Lynx1 Capital Management LP — 10% Owner
Shares
50,055
Price
$4.12
Total Value
$206.10K
Shares Held After
673,759
% of Holdings
7.4%
Beam Therapeutics Inc. (BEAM)
FMR LLC — 10% Owner
Shares
33,372
Price
$35.12
Total Value
$1.17M
Shares Held After
1,106,071
% of Holdings
2.9%
CalciMedica, Inc. (CALC)
Middleton Fred A — Director
Shares
248,972
Price
$0.80
Total Value
$200.00K
Shares Held After
1,063,272
% of Holdings
23.4%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
10,000
Price
$87.14
Total Value
$871.40K
Shares Held After
97,994
% of Holdings
9.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,000
Price
$87.12
Total Value
$435.60K
Shares Held After
107,994
% of Holdings
4.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,127
Price
$3.00
Total Value
$6.38K
Shares Held After
115,018
% of Holdings
1.8%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
21,072
Price
$78.49
Total Value
$1.65M
Shares Held After
245,571
% of Holdings
7.9%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
10,602
Price
$79.18
Total Value
$839.49K
Shares Held After
21,759
% of Holdings
32.8%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
1,000
Price
$347.27
Total Value
$347.27K
Shares Held After
0
% of Holdings
100.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
28,716
Price
$50.02
Total Value
$1.44M
Shares Held After
519,227
% of Holdings
5.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
100
Price
$87.00
Total Value
$8.70K
Shares Held After
60,137
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,337
Price
$86.51
Total Value
$980.76K
Shares Held After
60,137
% of Holdings
15.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,522
Price
$85.26
Total Value
$726.59K
Shares Held After
71,474
% of Holdings
10.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
419
Price
$86.39
Total Value
$36.20K
Shares Held After
60,137
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
582
Price
$85.24
Total Value
$49.61K
Shares Held After
60,556
% of Holdings
1.0%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
29,208
Price
$45.03
Total Value
$1.32M
Shares Held After
1,098,246
% of Holdings
2.6%
Definium Therapeutics, Inc. (DFTX)
Roberts Brandi — Chief Financial Officer
Shares
3,013
Price
$45.03
Total Value
$135.68K
Shares Held After
209,487
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
13,008
Price
$45.03
Total Value
$585.75K
Shares Held After
320,571
% of Holdings
3.9%
Greenland Mines Ltd (GRML)
El-Dada Riad Hussein — Director
Shares
175,000
Price
$0.23
Total Value
$40.55K
Shares Held After
175,000
% of Holdings
50.0%
Definium Therapeutics, Inc. (DFTX)
Wiley Matthew T. — Chief Commercial Officer
Shares
2,867
Price
$45.03
Total Value
$129.10K
Shares Held After
174,633
% of Holdings
1.6%
Definium Therapeutics, Inc. (DFTX)
Karlin Daniel — Chief Medical Officer
Shares
10,035
Price
$45.03
Total Value
$451.88K
Shares Held After
503,282
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$554.84
Total Value
$133.16K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$553.97
Total Value
$443.17K
Shares Held After
40,753
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,778
Price
$552.68
Total Value
$982.67K
Shares Held After
41,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,814
Price
$551.61
Total Value
$1.00M
Shares Held After
43,331
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,617
Price
$550.86
Total Value
$890.75K
Shares Held After
45,145
% of Holdings
3.5%
Showing 1–50 of 1415 transactions (page 1 of 29)